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Flight behaviour and panic disorder in humans 
 
Flight behaviour in humans is intensified by a candidate genetic risk factor for 
panic disorder: evidence from a translational model of fear and anxiety 
Panic Disorder (PD) is a serious and common psychiatric condition1 characterised 
chiefly by recurrent episodes of intense, uncontrollable fear known as panic attacks.2 
The underlying causal mechanism for PD is unknown3, however the discovery that 
drugs with clinical effectiveness against PD preferentially alter rodent flight 
behaviour suggests that PD reflects alterations in the brain systems that govern flight.4 
An association between PD and flight in humans is supported anecdotally by the 
tendency for PD sufferers to feel a strong urge to flee from the location where a panic 
attack occurs.2 Here we provide the first human empirical evidence for a PD-flight 
link, showing that flight behaviour is significantly more intense in carriers of a 
candidate genetic risk factor for PD than in non-carriers. 
Human flight behaviour was measured with a computerised translation of a 
rodent runway task (figure 1 a) designed to index fear-proneness behaviourally, as the 
intensity of flight effort in response to a pursuing threat stimulus.5 The genetic risk 
factor for PD used in this study was the C allele of the 102T/C single nucleotide 
polymorphism (rs6313) within the serotonin 2a receptor gene (HTR2A) on 
chromosome 13q14.2; the C allele in this SNP is known to be associated with 
increased susceptibility to pure but not co-morbid panic disorder (PD)6 as well as 
increased intensity of panic symptoms.7 All 200 participants (107 males) gave 
informed consent and self-identified as healthy Caucasians. Buccal cells were 
collected and DNA extracted using established methods, see Supplementary 
Information.  
The genotype distribution of rs6313 SNP in HTR2A was in Hardy–Weinberg 
equilibrium (χ2 = 0.632 df = 2, p = 0.73). There were no significant genotype effects 
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upon flight intensity (F (1,192) = 2.69, P = 0.070); however, carriers of the C risk 
allele displayed significantly greater flight intensity than TT individuals (F (1,194) = 
4.90, P = 0.033; Figure 1b). The construct validity of flight intensity as a specific 
measure of fear-proneness was supported by its significant positive association with 
scores on tissue damage fear (measured by the Fear Survey Schedule) (F (1,194) = 
5.92, P = 0.022) and its lack of a significant association with scores on Spielberger 
trait anxiety (F (1,194) = 0.01, P = 0.998), a widely accepted questionnaire measure 
of anxiety-proneness.8 Sex did not affect flight intensity in this model (F (1, 194) = 
1.50, P = 0.222) nor was there a significant allele x sex interaction (F (1, 194) = 1.56, 
P = 0.213). There was no significant interaction between tissue damage fear and 
rs6313 carrier status (C carrier or TT homozygote) (F (1,191) = 0.44, P = 0.511). 
In overview, therefore, our study is the first molecular genetic investigation of 
human defensive behaviour and the first study empirically to support in humans the 
hypothesis that panic disorder stems from alterations in the brain systems governing 
flight behaviour. However, although the HTR2A gene on chromosome 13q4-21 has 
previously been associated with PD, as a caveat it should be noted that the rs6313 
SNP in exon 1 of the coding sequence of the HTR2A gene is a synonymous (or silent) 
polymorphism. Therefore, its previously observed effects at the phenotypic level may 
be mediated not by changes in protein structure but via gene expression resulting, e.g., 
in changes in serotonin receptor density. As rs6313 is part of a 4-SNP haplotype 
(rs6311, rs1328674, rs6313, rs6314), future attempts at understanding the causative 
mechanisms underlying the association between the C allele in rs6313 and flight 
intensity should ultimately consider these other linked polymorphisms.9,10 
While our findings suggest that PD is mediated by the brain systems that 
govern flight behaviour, our molecular genetic design could not reveal which brain 
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systems may be implicated. In rats electrical stimulation of the dorsal periaqueductal 
grey (PAG) prompts flight behaviour suggesting that this structure may be 
particularly relevant to determining susceptibility to PD. Therefore a desirable next 
step would be functional neuroimaging studies using our runway task that explore 
brain activity during flight. Additionally it would be desirable from an individual 
perspective to explore whether or not individuals that flee intensely and report being 
especially prone to fear show particularly intense activity in the target brain systems. 
Finally, a strength of the use of healthy participants in this study is that the 
heightened flight reactions of C allele carriers cannot easily be explained as an 
outcome of acute symptomatic effects of PD or a side effect of medication for PD but 
instead may be part of an inherited trait of fearfulness/flight-proneness3 that could 
ultimately constitute an endophenotype11 for PD. However, this view should be 
tempered with the consideration that individuals without the C allele (i.e., who had the 
TT genotype) are relatively rare (only 18 males and 12 female in the present sample). 
The minority status of the TT individuals, therefore, implies that molecular genetic 
studies of the present type should invert the interpretation of their results, portraying 
TT carriers as unusually resistant to fear/PD rather than the carriers of the C allele as 
particularly prone to fear/PD. 
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Figure legend 
Figure 1 (a) The Joystick Operated Runway Task, a computerised human 
translation of the Mouse Defense Test Battery. The participants used a force-sensing 
joystick apparatus (PH-JS1, Psyal, London, UK) to control the speed of a cursor 
(green dot) pursued along an on-screen runway by a threat stimulus (red dot). In order 
to provide aversive motivation for flight, if the red dot caught the green dot 
participants received an unpleasant but harmless 115dB white noise burst lasting 
250ms. In order to mimic the calorie cost of flight in real threat situations, the velocity 
of the green dot increased in proportion to the force applied to the joystick. In order to 
control for individual differences in strength and motivation, the minimum force 
required for the green dot cursor to reach escape velocity was set at 50% of whatever 
maximum force that the participant exerted during an earlier calibration session. (b) 
Flight intensity was significantly increased by carrying the C allele of the 102T/C 
polymorphism (rs6313) within the serotonin 2a receptor gene (HTR2A; error bars 
represent 1 SEM; *P < 0.05.). 
